Lv7
3370 积分 2023-09-25 加入
Venetoclax combined with intensive chemotherapy as induction chemotherapy in newly diagnosed AML with FLT3-ITD-mutation
14天前
已完结
Seven-day Venetoclax Combined With Dose-adjusted Intensive Chemotherapy as Induction Treatment in Newly Diagnosed Acute Myeloid Leukemia
30天前
已完结
Venetoclax combined with homoharringtonine, cytarabine and aclacinomycin as induction therapy in newly diagnosed Chinese acute myeloid leukaemia patients: A multicentre phase II study
30天前
已完结
DNMT3A R882H mutation drives daunorubicin resistance in acute myeloid leukemia via regulating NRF2/NQO1 pathway
1个月前
已完结
Mitochondrial metabolism sustains DNMT3A-R882-mutant clonal haematopoiesis
1个月前
已完结
Genomic and transcriptomic determinants of clinical outcomes in patients with AML and DNMT3A mutations
1个月前
已完结
Targeting DNMT3A-mediated oxidative phosphorylation to overcome ibrutinib resistance in mantle cell lymphoma
1个月前
已完结
The R882H DNMT3A hot spot mutation stabilizes the formation of large DNMT3A oligomers with low DNA methyltransferase activity
1个月前
已完结
Mutations of R882 change flanking sequence preferences of the DNA methyltransferase DNMT3A and cellular methylation patterns
1个月前
已完结
DNMT3A alterations associated with myeloid malignancies dictate differential responses to hypomethylating agents
1个月前
已完结
皖公网安备34019202002308
